- Home
- RJET vs ATTO Comparison
RJET vs ATTO Comparison
Compare RJET & ATTO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | RJET | ATTO |
|---|---|---|
| Founded | 1982 | N/A |
| Country | United States | United States |
| Employees | 8400 | N/A |
| Industry | | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 830.1M | 1.0B |
| IPO Year | 2009 | 2026 |
Fundamental Metrics
Financial Performance| Metric | RJET | ATTO |
|---|---|---|
| Price | $17.62 | $22.21 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 62.0K | ★ 197.5K |
| Earning Date | 04-29-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 15.43 | N/A |
| EPS | ★ 1.26 | N/A |
| Revenue | ★ $1,676,500,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $13.72 | ★ N/A |
| Revenue Growth | ★ 13.74 | N/A |
| 52 Week Low | $15.37 | $16.15 |
| 52 Week High | $26.70 | $28.00 |
Technical Indicators
Market Signals| Indicator | RJET | ATTO |
|---|---|---|
| Relative Strength Index (RSI) | 45.28 | 58.30 |
| Support Level | $16.81 | $17.50 |
| Resistance Level | $22.31 | $24.89 |
| Average True Range (ATR) | 0.61 | 2.69 |
| MACD | 0.04 | 0.01 |
| Stochastic Oscillator | 50.71 | 57.01 |
Price Performance
Historical ComparisonAbout RJET Republic Airways Holdings Inc.
Republic Airways Holdings Inc is a regional airline mainly in North America. The company provides scheduled passenger service through its mainline partnerships with American Airlines, Delta Air Lines, and United Airlines. Republic offers scheduled passenger service on several daily flights to various cities in the United States, Canada, Mexico, and the Caribbean. It exclusively operates the dual-class Embraer E170/175 family of aircraft, and provides its services under the American Eagle, Delta Connection, or United Express brands. The company is organized and operates as one operating and reportable segment: regional airline services.
About ATTO Attovia Therapeutics Inc. Common Stock
Attovia Therapeutics Inc is a clinical stage biotechnology company focused on research and development of therapeutic products in the fields of immune-mediated diseases. Its product pipeline includes ATTO-1310 and ATTO-2306 for immune-dermatology indications and ATTO-1091 for inflammatory diseases, including inflammatory bowel disease (IBD). The company's product candidates are developed using its ATTOBODY biologics platform.